Health and Fitness Health and Fitness
Thu, August 26, 2010
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis voltooit aankoop meerderheidsbelang Alcon van Nestl©
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis completa acquisto da Nestl© di interesse di maggioranza su Alcon
Wed, August 25, 2010
[ Wed, Aug 25th 2010 ] - Market Wire
Novartis Completes Purchase from Nestl© of Majority Interest in Alcon
[ Wed, Aug 25th 2010 ] - Market Wire
Medtronic, Boston Scientific, St. Jude Medical, Haemonetics and Cyberonics
[ Wed, Aug 25th 2010 ] - Market Wire
Medtronic Response to Pakistan Flooding Relief Efforts
[ Wed, Aug 25th 2010 ] - Market Wire
PPD Appoints Neil McCullough, Ph.D., Vice President of Quality Management Systems
[ Wed, Aug 25th 2010 ] - Market Wire
The Fourth Product Candidate Containing Antigenics' QS-21 In Phase 3 Clinical Development
[ Wed, Aug 25th 2010 ] - Market Wire
NexMed To Present at the Rodman & Renshaw 12th Annual Healthcare Conference
[ Wed, Aug 25th 2010 ] - Market Wire
Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2011
[ Wed, Aug 25th 2010 ] - Market Wire
Impax Pharmaceuticals Completes Enrollment in ADV .. Phase III Trial of IPX066 in Parkinsona?s Disease
[ Wed, Aug 25th 2010 ] - Market Wire
HEALTH NET GANA PREMIO EN EL PROGRAMA NATIONAL MATURE MEDIA AWARDS 2010
[ Wed, Aug 25th 2010 ] - Market Wire
Health Net Wins Award in 2010 National Mature Media Awards Program
[ Wed, Aug 25th 2010 ] - Market Wire
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
[ Wed, Aug 25th 2010 ] - Market Wire
Celgene Expects to Receive a Paragraph IV Notification of an ANDA Filing for REVLIMID®
[ Wed, Aug 25th 2010 ] - Market Wire
Exclusive Partnership between Healthways, MedNetw .. of Social Networks to Improve Health, Well-Being
[ Wed, Aug 25th 2010 ] - Market Wire
Northstar Healthcare Calls Special Meeting of Shareholders and Amends Private Placement Agreement
[ Wed, Aug 25th 2010 ] - Market Wire
Somaxon Pharmaceuticals Announces Silenor® Co-Promotion Agreement with Procter & Gamble
[ Wed, Aug 25th 2010 ] - Market Wire
Inspire Announces Amendment to Ophthalmic Collaboration
Tue, August 24, 2010
[ Tue, Aug 24th 2010 ] - Market Wire
Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars
[ Tue, Aug 24th 2010 ] - Market Wire
Emergent BioSolutions Announces Appointment of Jo .. rhuber, M.D. to the Companya?s Board of Directors
[ Tue, Aug 24th 2010 ] - Market Wire
Jazz Pharmaceuticals, UCB Pharmaceuticals, Pfizer, Eli Lilly and Co. and Forest Laboratories
[ Tue, Aug 24th 2010 ] - Market Wire
AGA Medical Files Suit Against W.L. Gore Alleging Patent Infringement
[ Tue, Aug 24th 2010 ] - Market Wire
Cerus Signs Agreement to Acquire INTERCEPT Blood System Asian Commercial Rights from BioOne
[ Tue, Aug 24th 2010 ] - Market Wire
Le systme PureGrafta" de Cytori reoit l'approbati .. urop©enne pour les proc©dures de lipo-injection
[ Tue, Aug 24th 2010 ] - Market Wire
Voorlopige gegevens onderzoek anti-JCV antilichamen gepubliceerd in Annals of Neurology
[ Tue, Aug 24th 2010 ] - Market Wire
Donn©es pr©liminaires venant appuyer le test da .. s anti-JCV publi©es dans les Annals of Neurology
[ Tue, Aug 24th 2010 ] - Market Wire
Bernstein Liebhard LLP Announces Class Action Has .. led on Behalf of Investors in Almost Family, Inc.
[ Tue, Aug 24th 2010 ] - Market Wire
BioAlliance Pharma Announces the Launch of Oravig .. s Commercial Partner, Strativa/Par Pharmaceutical
[ Tue, Aug 24th 2010 ] - Market Wire
Publicados en Annals of Neurology los datos preli .. de investigacin sobre anticuerpos contra el virus
[ Tue, Aug 24th 2010 ] - Market Wire
Dati preliminari a sostegno di un'analisi investi .. il virus JC, pubblicati negli Annali di neurolog

Dati preliminari a sostegno di un'analisi investigativa sugli anticorpi contro il virus JC, pubblicati negli Annali di neurolog


Published on 2010-08-24 06:45:58 - Market Wire
  Print publication without navigation


WESTON, Mass.--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) e [ Elan Corporation, plc ] (NYSE: ELN) hanno annunciato oggi che sugli Annali di neurologia sono stati pubblicati dati relativi a un'analisi investigativa in due fasi per il rilevamento di anticorpi contro il virus JC (JCV) nel siero e nel plasma umano. L'analisi attualmente in corso di valutazione negli studi clinici in quanto strumento potenziale per la stratificazione del rischio nei pazienti trattati con [ TYSABRI® ] (natalizumab). I dati derivati da questa analisi preliminare sono stati emessi online e saranno pubblicati nell'edizione di settembre della rivista.

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.

Contributing Sources